Article

Actress Farrah Fawcett dies of cancer at 62

Author(s):

1970s "It Girl" and Charlie's Angel's starlet Farrah Fawcett died of anal cancer today at age 62. "After a long and brave battle with cancer, our beloved Farrah has passed away. Although this is an extremely difficult time for her family and friends, we take comfort in the beautiful times that we shared with Farrah over the years and the knowledge that her life brought joy to so many people around the world," O'Neal said in a statement released by Fawcett's publicist.First diagnosed with anal cancer in 2006 and declared cancer-free in 2007, Fawcett sought out the best treatment available from specialists from UCLA to Germany, but the cancer returned a few months later and spread to her liver.Just over a month before her death Fawcett shared an extremely intimate and personal look at her battle with cancer in the TV documentary Farrah's Story, which aired on NBC in May. Fawcett filmed much of the footage herself with a hand-held camera, along with help from her long-time partner Ryan O'Neal and close friend Alana Stewart. According to news reports, an NBC spokeswoman confirmed that the network has plans to air a follow-up to the documentary, which attracted almost 9 million viewers.In the last days of Fawcett's life, O'Neal and others close to her sat down for an exclusive interview with Barbara Walters, which is scheduled to air on ABC's 20/20 at 10 p.m. (EDT) tonight.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of doctor.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of man.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Related Content